相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Do Post-Translational Modifications Influence Protein Aggregation in Neurodegenerative Diseases: A Systematic Review
Larissa-Nele Schaffert et al.
BRAIN SCIENCES (2020)
Isoindole Linkages Provide a Pathway for DOPAL-Mediated Cross-Linking of α-Synuclein
Jonathan W. Werner-Allen et al.
BIOCHEMISTRY (2018)
DOPAL derived alpha-synuclein oligomers impair synaptic vesicles physiological function
N. Plotegher et al.
SCIENTIFIC REPORTS (2017)
Inactivation of glyceraldehyde-3-phosphate dehydrogenase by the dopamine metabolite, 3,4-dihydroxyphenylacetaldehyde
Brigitte C. Vanle et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Lysines, Achilles' heel in alpha-synuclein conversion to a deadly neuronal endotoxin
Nicoletta Plotegher et al.
AGEING RESEARCH REVIEWS (2016)
Toxic Dopamine Metabolite DOPAL Forms an Unexpected Dicatechol Pyrrole Adduct with Lysines of α-Synuclein
Jon W. Werner-Allen et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
Antioxidant-Mediated Modulation of Protein Reactivity for 3,4-Dihydroxyphenylacetaldehyde, a Toxic Dopamine Metabolite
David G. Anderson et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2016)
Oligomerization and Membrane-binding Properties of Covalent Adducts Formed by the Interaction of α-Synuclein with the Toxic Dopamine Metabolite 3,4-Dihydroxyphenylacetaldehyde (DOPAL)
Cristian Follmer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
A Clinical Frailty Index in Aging Mice: Comparisons With Frailty Index Data in Humans
Jocelyne C. Whitehead et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2014)
Aldehyde dehydrogenase variation enhances effect of pesticides associated with Parkinson disease
Arthur G. Fitzmaurice et al.
NEUROLOGY (2014)
Neuroimmunological processes in Parkinson's disease and their relation to alpha-synuclein: microglia as the referee between neuronal processes and peripheral immunity
Vanesa Sanchez-Guajardo et al.
ASN NEURO (2013)
Changes in properties of serine 129 phosphorylated α-synuclein with progression of Lewy-type histopathology in human brains
Douglas G. Walker et al.
EXPERIMENTAL NEUROLOGY (2013)
Reactive aldehydes - second messengers of free radicals in diabetes mellitus
M. Jaganjac et al.
FREE RADICAL RESEARCH (2013)
Identification of aldehyde dehydrogenase 1A1 modulators using virtual screening
Vinayaka Kotraiah et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2013)
Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease
Sheila M. Fleming et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2013)
Catechol and aldehyde moieties of 3,4-dihydroxyphenylacetaldehyde contribute to tyrosine hydroxylase inhibition and neurotoxicity
Lydia M. M. Vermeer et al.
BRAIN RESEARCH (2012)
Overview of Tyrosine Hydroxylase in Parkinson's Disease
Yanzhen Zhu et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2012)
α-Synuclein expression and Nrf2 deficiency cooperate to aggravate protein aggregation, neuronal death and inflammation in early-stage Parkinson's disease
Isabel Lastres-Becker et al.
HUMAN MOLECULAR GENETICS (2012)
Neurodegeneration and Motor Dysfunction in Mice Lacking Cytosolic and Mitochondrial Aldehyde Dehydrogenases: Implications for Parkinson's Disease
Margaret Chia-Ying Wey et al.
PLOS ONE (2012)
Dopamine-derived biological reactive intermediates and protein modifications: Implications for Parkinson's disease
Yunden Jinsmaa et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2011)
The lipid peroxidation products 4-oxo-2-nonenal and 4-hydroxy-2-nonenal promote the formation of α-synuclein oligomers with distinct biochemical, morphological, and functional properties
Thomas Nasstrom et al.
FREE RADICAL BIOLOGY AND MEDICINE (2011)
Oxidation of 3,4-Dihydroxyphenylacetaldehyde, a Toxic Dopaminergic Metabolite, to a Semiquinone Radical and an ortho-Quinone
David G. Anderson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Elevated Tonic Extracellular Dopamine Concentration and Altered Dopamine Modulation of Synaptic Activity Precede Dopamine Loss in the Striatum of Mice Overexpressing Human α-Synuclein
Hoa A. Lam et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2011)
Inhibition and covalent modification of tyrosine hydroxylase by 3,4-dihydroxyphenylacetaldehyde, a toxic dopamine metabolite
Lydia M. Mexas et al.
NEUROTOXICOLOGY (2011)
In vivo demonstration that α-synuclein oligomers are toxic
Beate Winner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Nest building performance following MPTP toxicity in mice
Thomas Nikolaj Sager et al.
BEHAVIOURAL BRAIN RESEARCH (2010)
Increased Expression of α-Synuclein Reduces Neurotransmitter Release by Inhibiting Synaptic Vesicle Reclustering after Endocytosis
Venu M. Nemani et al.
NEURON (2010)
The Neurotoxicity of DOPAL: Behavioral and Stereological Evidence for Its Role in Parkinson Disease Pathogenesis
W. Michael Panneton et al.
PLOS ONE (2010)
Gait dynamics in Parkinson's disease: Common and distinct behavior among stride length, gait variability, and fractal-like scaling
Jeffrey M. Hausdorff
CHAOS (2009)
Products of Oxidative Stress Inhibit Aldehyde Oxidation and Reduction Pathways in Dopamine Catabolism Yielding Elevated Levels of a Reactive Intermediate
Yunden Jinsmaa et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2009)
Protein Reactivity of 3,4-Dihydroxyphenylacetaldehyde, a Toxic Dopamine Metabolite, Is Dependent on Both the Aldehyde and the Catechol
Jennifer N. Rees et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2009)
Gait disorders and balance disturbances in Parkinsonʼs disease: clinical update and pathophysiology
Tjitske A Boonstra et al.
CURRENT OPINION IN NEUROLOGY (2009)
Pre-fibrillar α-synuclein variants with impaired β-structure increase neurotoxicity in Parkinson's disease models
Damla Pinar Karpinar et al.
EMBO JOURNAL (2009)
Tests to assess motor phenotype in mice: a user's guide
Simon P. Brooks et al.
NATURE REVIEWS NEUROSCIENCE (2009)
Frailty in Parkinson's disease and its clinical implications
Naslya N. Ahmed et al.
PARKINSONISM & RELATED DISORDERS (2008)
Effect of 4-hydroxy-2-nonenal modification α-synuclein aggregation
Zhijie Qin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Inhibition of the oxidative metabolism of 3,4-dihydroxyphenylacetaldehyde, a reactive intermediate of dopamine metabolism, by 4-hydroxy-2-nonenal
V. R. Florang et al.
NEUROTOXICOLOGY (2007)
Behavioral models of Parkinson's disease in rodents: A new look at an old problem
Gloria E. Meredith et al.
MOVEMENT DISORDERS (2006)
Locomotor activity and evoked dopamine release are reduced in mice overexpressing A30P-mutated human α-synuclein
L Yavich et al.
NEUROBIOLOGY OF DISEASE (2005)
ALDH1 mRNA: presence in human dopamine neurons and decreases in substantia nigra in Parkinson's disease and in the ventral tegmental area in schizophrenia
D Galter et al.
NEUROBIOLOGY OF DISEASE (2003)
Covalent modification of amino acid nucleophiles by the lipid peroxidation products 4-hydroxy-2-nonenal and 4-oxo-2-nonenal
JA Doorn et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2002)
Differential neuropathological alterations in transgenic mice expressing α-synuclein from the platelet-derived growth factor and Thy-1 promoters
E Rockenstein et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2002)
α-Synuclein is phosphorylated in synucleinopathy lesions
H Fujiwara et al.
NATURE CELL BIOLOGY (2002)
Complex I and Parkinson's disease
JT Greenamyre et al.
IUBMB LIFE (2001)
MPTP susceptibility in the mouse: Behavioral, neurochemical, and histological analysis of gender and strain differences
M Sedelis et al.
BEHAVIOR GENETICS (2000)
分享论文
